Cesarean section prophylaxis

Comparison of two doses with three doses of mezlocillin

W. R. Crombleholme, J. R. Green, M. Ohm-Smith, D. Dahrouge, V. DeKay, A. Rideout, Richard L Sweet

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A prospective randomized double-blind comparison of two doses, with three doses of mezlocillin for nonelective cesarean section prophylaxis was performed. One hundred seven (107) patients were evaluated. Mezlocillin (4 g) was given post-cord clamping and then at 4-h intervals for a total of two doses or three doses. The incidence of febrile morbidity was lower in the three-dose group (2 of 46, 4%) than the two-dose group (14 of 61, 23%) (P < 0.02). However, the incidence of infectious morbidity was not different between the three-dose group (3 of 46, 7%) and the two-dose group (10 of 61, 16%), and the incidence of endomyometritis was similar in the two groups (6.5% vs 9.8%). Among failures of prophylaxis there were no differences compared to successes in the number of potential commensals or potential pathogens cultured from amniotic fluid. However, the proportion of failures among patients with both commensals and potential pathogens isolated (10/58) was significantly greater than among patients with none or only commensals isolated (1/37) (P < 0.03). We found mezlocillin to be an effective agent for perioperative cesarean section prophylaxis with two doses as effective as three doses. The presence of clinically important organisms in the amniotic fluid at the time of operation typified patients with postoperative infectious complications despite perioperative prophylaxis.

Original languageEnglish (US)
Pages (from-to)71-75
Number of pages5
JournalAmerican Journal of Reproductive Immunology and Microbiology
Volume13
Issue number3
StatePublished - 1987

Fingerprint

Mezlocillin
Cesarean Section
Amniotic Fluid
Incidence
Morbidity
Endometritis
Constriction
Fever

ASJC Scopus subject areas

  • Immunology
  • Obstetrics and Gynecology

Cite this

Crombleholme, W. R., Green, J. R., Ohm-Smith, M., Dahrouge, D., DeKay, V., Rideout, A., & Sweet, R. L. (1987). Cesarean section prophylaxis: Comparison of two doses with three doses of mezlocillin. American Journal of Reproductive Immunology and Microbiology, 13(3), 71-75.

Cesarean section prophylaxis : Comparison of two doses with three doses of mezlocillin. / Crombleholme, W. R.; Green, J. R.; Ohm-Smith, M.; Dahrouge, D.; DeKay, V.; Rideout, A.; Sweet, Richard L.

In: American Journal of Reproductive Immunology and Microbiology, Vol. 13, No. 3, 1987, p. 71-75.

Research output: Contribution to journalArticle

Crombleholme, WR, Green, JR, Ohm-Smith, M, Dahrouge, D, DeKay, V, Rideout, A & Sweet, RL 1987, 'Cesarean section prophylaxis: Comparison of two doses with three doses of mezlocillin', American Journal of Reproductive Immunology and Microbiology, vol. 13, no. 3, pp. 71-75.
Crombleholme WR, Green JR, Ohm-Smith M, Dahrouge D, DeKay V, Rideout A et al. Cesarean section prophylaxis: Comparison of two doses with three doses of mezlocillin. American Journal of Reproductive Immunology and Microbiology. 1987;13(3):71-75.
Crombleholme, W. R. ; Green, J. R. ; Ohm-Smith, M. ; Dahrouge, D. ; DeKay, V. ; Rideout, A. ; Sweet, Richard L. / Cesarean section prophylaxis : Comparison of two doses with three doses of mezlocillin. In: American Journal of Reproductive Immunology and Microbiology. 1987 ; Vol. 13, No. 3. pp. 71-75.
@article{f466e0fec52b4d25ab263f536db10d6d,
title = "Cesarean section prophylaxis: Comparison of two doses with three doses of mezlocillin",
abstract = "A prospective randomized double-blind comparison of two doses, with three doses of mezlocillin for nonelective cesarean section prophylaxis was performed. One hundred seven (107) patients were evaluated. Mezlocillin (4 g) was given post-cord clamping and then at 4-h intervals for a total of two doses or three doses. The incidence of febrile morbidity was lower in the three-dose group (2 of 46, 4{\%}) than the two-dose group (14 of 61, 23{\%}) (P < 0.02). However, the incidence of infectious morbidity was not different between the three-dose group (3 of 46, 7{\%}) and the two-dose group (10 of 61, 16{\%}), and the incidence of endomyometritis was similar in the two groups (6.5{\%} vs 9.8{\%}). Among failures of prophylaxis there were no differences compared to successes in the number of potential commensals or potential pathogens cultured from amniotic fluid. However, the proportion of failures among patients with both commensals and potential pathogens isolated (10/58) was significantly greater than among patients with none or only commensals isolated (1/37) (P < 0.03). We found mezlocillin to be an effective agent for perioperative cesarean section prophylaxis with two doses as effective as three doses. The presence of clinically important organisms in the amniotic fluid at the time of operation typified patients with postoperative infectious complications despite perioperative prophylaxis.",
author = "Crombleholme, {W. R.} and Green, {J. R.} and M. Ohm-Smith and D. Dahrouge and V. DeKay and A. Rideout and Sweet, {Richard L}",
year = "1987",
language = "English (US)",
volume = "13",
pages = "71--75",
journal = "American Journal of Reproductive Immunology",
issn = "8755-8920",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Cesarean section prophylaxis

T2 - Comparison of two doses with three doses of mezlocillin

AU - Crombleholme, W. R.

AU - Green, J. R.

AU - Ohm-Smith, M.

AU - Dahrouge, D.

AU - DeKay, V.

AU - Rideout, A.

AU - Sweet, Richard L

PY - 1987

Y1 - 1987

N2 - A prospective randomized double-blind comparison of two doses, with three doses of mezlocillin for nonelective cesarean section prophylaxis was performed. One hundred seven (107) patients were evaluated. Mezlocillin (4 g) was given post-cord clamping and then at 4-h intervals for a total of two doses or three doses. The incidence of febrile morbidity was lower in the three-dose group (2 of 46, 4%) than the two-dose group (14 of 61, 23%) (P < 0.02). However, the incidence of infectious morbidity was not different between the three-dose group (3 of 46, 7%) and the two-dose group (10 of 61, 16%), and the incidence of endomyometritis was similar in the two groups (6.5% vs 9.8%). Among failures of prophylaxis there were no differences compared to successes in the number of potential commensals or potential pathogens cultured from amniotic fluid. However, the proportion of failures among patients with both commensals and potential pathogens isolated (10/58) was significantly greater than among patients with none or only commensals isolated (1/37) (P < 0.03). We found mezlocillin to be an effective agent for perioperative cesarean section prophylaxis with two doses as effective as three doses. The presence of clinically important organisms in the amniotic fluid at the time of operation typified patients with postoperative infectious complications despite perioperative prophylaxis.

AB - A prospective randomized double-blind comparison of two doses, with three doses of mezlocillin for nonelective cesarean section prophylaxis was performed. One hundred seven (107) patients were evaluated. Mezlocillin (4 g) was given post-cord clamping and then at 4-h intervals for a total of two doses or three doses. The incidence of febrile morbidity was lower in the three-dose group (2 of 46, 4%) than the two-dose group (14 of 61, 23%) (P < 0.02). However, the incidence of infectious morbidity was not different between the three-dose group (3 of 46, 7%) and the two-dose group (10 of 61, 16%), and the incidence of endomyometritis was similar in the two groups (6.5% vs 9.8%). Among failures of prophylaxis there were no differences compared to successes in the number of potential commensals or potential pathogens cultured from amniotic fluid. However, the proportion of failures among patients with both commensals and potential pathogens isolated (10/58) was significantly greater than among patients with none or only commensals isolated (1/37) (P < 0.03). We found mezlocillin to be an effective agent for perioperative cesarean section prophylaxis with two doses as effective as three doses. The presence of clinically important organisms in the amniotic fluid at the time of operation typified patients with postoperative infectious complications despite perioperative prophylaxis.

UR - http://www.scopus.com/inward/record.url?scp=0023256673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023256673&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 71

EP - 75

JO - American Journal of Reproductive Immunology

JF - American Journal of Reproductive Immunology

SN - 8755-8920

IS - 3

ER -